Blog - Page 22 of 5659 - QualityStocks

ThursdayMay 21, 2026 11:26 am

QualityStocksNewsBreaks – Resilient Energy Inc. (OTCID: RENI) Forms Joint Venture to Expand Oilfield Services Operations

Resilient Energy (OTCID: RENI) announced that its wholly owned subsidiary, Bullet SWD LLC, has entered into a joint venture agreement with an established U.S.-based oilfield services operator generating more than $15 million in annual revenue, with a customer base that includes multiple Fortune 500 energy companies. Under the agreement, RENI will supply and maintain specialized equipment supporting saltwater disposal and related oilfield operations, with the company expecting the partnership to create a high-margin revenue stream and begin generating initial revenue before the end of summer 2026. To view the full press release, visit https://ibn.fm/IVTVS About Resilient Energy Inc. Resilient Energy Inc. (OTC: RENI) is…

ThursdayMay 21, 2026 11:15 am

Oncotelic Therapeutics Inc. (OTLC) Proving Small Biotech Can Out-Innovate Big Pharma with 28 Million Reasons Why

The global AI in drug-discovery market was valued at approximately $3.25 billion in 2026 and is projected to reach more than $10 billion by 2031. Oncotelic's central technology, the PDAOAI platform, was designed from the outset to be something more than a research accelerator for internal programs. The most significant development to date came when Oncotelic announced the successful integration of approximately 28 million scientific abstracts, into its PDAOAI platform. Artificial intelligence is no longer a buzzword in the life sciences; rather, it is rapidly becoming the defining infrastructure layer of modern drug development. The companies that control the most intelligent platforms…

ThursdayMay 21, 2026 11:08 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Launches MyndSystem Cognitive Support Platform

BioAdaptives (OTC: BDPT) a science-driven health and wellness company, announced the launch of MyndSystem, a dual-phase cognitive support platform combining its daytime MyndMed formula with newly released nighttime recovery product MyndRenew into a 24-hour stimulant-free cognitive support system. The company said MyndSystem was originally developed for professional combat athletes and is designed to address both daytime mental performance and overnight neural recovery. MyndMed is a 12-ingredient daytime formula intended to support focus, mental clarity and cognitive endurance, while MyndRenew is a 14-ingredient nighttime formula designed to support the brain’s overnight repair processes, according to the company. BioAdaptives said the complete MyndSystem platform is now available for purchase as a 30-day supply through direct purchase or subscription. To view…

ThursdayMay 21, 2026 10:45 am

QualityStocksNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced the pricing of its underwritten public offering in connection with its uplisting to the Nasdaq Capital Market, offering 2.4 million common shares at US$6.25 per share for expected gross proceeds of approximately US$15 million, excluding any exercise of the underwriter’s option to purchase up to an additional 360,000 shares. Joseph Gunnar & Co. LLC is acting as sole book-running manager for the offering, with trading on Nasdaq expected to begin May 20, 2026, under the…

ThursdayMay 21, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Doubling Down on Clayton Silver Mine Exploration Amid Upturn in Silver Prices

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, continues to bolster its foundations amid surging demand for silver With its 100%-owned Clayton Silver Project, the company is looking to unlock its largely untapped potential, ultimately stamping its position as an integral player in the global silver production market In May 2026, the company announced that it’s making good progress on a non-brokered private placement financing for aggregate gross proceeds of up to CAN$2,000,000, with…

ThursdayMay 21, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is expanding its AI voice analytics platform to include fatigue detection alongside drug and alcohol impairment screening. MindBio filed a patent application covering detection of neurologically active substances and fatigue through voice analysis. Fatigue prediction module will be added to Edge AI Intoxication Detection Kiosks targeted at industrial workplaces. Management says commercial testing of kiosk hardware and software remains on track for late Q2 2026. The company is positioning its technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing…

ThursdayMay 21, 2026 9:30 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration

ParaZero Technologies (NASDAQ: PRZO) announced the successful completion of its first live U.S. demonstration of its DefendAir counter-UAS net launcher system following SOF Week 2026 in Tampa, showcasing the platform to defense and security stakeholders including Tier-1 defense integrators, special forces, law enforcement representatives and distributors. During the demonstration, the DefendAir system achieved a 100% success rate intercepting multiple fast incoming FPV drone threats, supporting discussions around potential procurement, integration and deployment opportunities in U.S. and international defense markets. To view the full press release, visit https://ibn.fm/02rcN About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart,…

ThursdayMay 21, 2026 9:00 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Files First Quarterly Report Following Kepler Transaction

American Fusion (OTC: AMFN), a company developing advanced fusion energy technologies, including its Texatron(TM) Fusion Engine(TM) platform, filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, marking its first quarterly report reflecting the consolidated operations of American Fusion and Kepler Fusion Technologies following the closing of the previously announced reverse-merger share exchange on Feb. 27, 2026. To view the full press release, visit: https://ibn.fm/fX9Bj About American Fusion Inc. American Fusion Inc. (OTC: AMFN) is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The Company is advancing the…

ThursdayMay 21, 2026 9:00 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Targets the Software Layer Powering Autonomous Warfare

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI is developing software designed to help drones operate in GPS-denied and electronically contested environments The company’s Overwatch platform focuses on autonomous navigation and precision targeting without requiring additional hardware Growing global investment in electronic warfare, autonomous defense systems, and counterspace resilience is accelerating demand for software-defined military capability With modern warfare rapidly evolving, the competitive advantage is shifting from hardware to software systems that enable autonomy, precision, and resilience in contested environments. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is strategically positioning itself…

WednesdayMay 20, 2026 2:00 pm

QualityStocksNewsBreaks – Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering

Sunshine Biopharma (NASDAQ: SBFM) announced the closing of its previously announced public offering, generating approximately $6 million in gross proceeds before fees and expenses through the sale of 12 million common units, each including common stock or pre-funded warrants and two Series C warrants. The company said net proceeds will be used for general corporate purposes and working capital, with potential additional gross proceeds of approximately $12 million if the Series C warrants are fully exercised for cash, while Aegis Capital acted as exclusive placement agent. To view the full press release, visit https://ibn.fm/00kUr About Sunshine Biopharma Inc. Sunshine Biopharma currently markets 60 generic prescription drugs in…

Site Search

Company Search